INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2015
|
Net Assets |
£239m |
|
Net Assets per share |
602p |
|
Share price |
541p |
|
Total value of unquoted investments |
£21m |
|
Total number of portfolio companies |
92 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
8.0 |
|
Amgen |
8.0 |
|
Regeneron |
7.6 |
|
Gilead |
7.1 |
|
Alexion |
5.2 |
|
Biogen |
4.8 |
|
Biomarin |
3.5 |
|
Vertex |
3.4 |
|
Ophthotech |
3.3 |
|
Incyte |
2.8 |
|
|
----------- |
|
Total |
53.7 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
54 |
|
Turning Profitable 2016 |
9 |
|
Unprofitable |
37 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
83 |
|
Europe & UK |
17 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
92 |
|
Unquoted |
8 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
25 JANUARY 2016